The Short Version
The evidence supports a narrower claim that big pharmaceutical companies have mostly abandoned male contraceptive development. It does not support the broader claim that pharmaceutical companies do not promote male contraceptives at all, because smaller pharma and biotech firms are actively developing and publicizing male-contraceptive products. The statement overstates a real trend into an absolute.